日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Quantitative phosphoproteomic analysis identifies the potential therapeutic target EphA2 for overcoming sorafenib resistance in hepatocellular carcinoma cells

定量磷酸化蛋白质组学分析确定了克服肝细胞癌细胞索拉非尼耐药性的潜在治疗靶点 EphA2

Chih-Ta Chen, Li-Zhu Liao, Ching-Hui Lu, Yung-Hsuan Huang, Yu-Kie Lin, Jung-Hsin Lin, Lu-Ping Chow

Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study

通过人类白细胞抗原基因分型和全基因组关联研究抗甲状腺药物引起的粒细胞缺乏症的遗传决定因素

Pei-Lung Chen, Shyang-Rong Shih, Pei-Wen Wang, Ying-Chao Lin, Chen-Chung Chu, Jung-Hsin Lin, Szu-Chi Chen, Ching-Chung Chang, Tien-Shang Huang, Keh Sung Tsai, Fen-Yu Tseng, Chih-Yuan Wang, Jin-Ying Lu, Wei-Yih Chiu, Chien-Ching Chang, Yu-Hsuan Chen, Yuan-Tsong Chen, Cathy Shen-Jang Fann, Wei-Shiung

When cytokinin, a plant hormone, meets the adenosine A2A receptor: a novel neuroprotectant and lead for treating neurodegenerative disorders?

当植物激素细胞分裂素遇到腺苷 A2A 受体时:会产生一种新型神经保护剂并可用于治疗神经退行性疾病?

Yi-Chao Lee, Ying-Chen Yang, Chuen-Lin Huang, Tsun-Yung Kuo, Jung-Hsin Lin, De-Ming Yang, Nai-Kuei Huang

A new drug design targeting the adenosinergic system for Huntington's disease

针对亨廷顿氏病腺苷系统的新药物设计

Nai-Kuei Huang, Jung-Hsin Lin, Jiun-Tsai Lin, Chia-I Lin, Eric Minwei Liu, Chun-Jung Lin, Wan-Ping Chen, Yuh-Chiang Shen, Hui-Mei Chen, Jhih-Bin Chen, Hsing-Lin Lai, Chieh-Wen Yang, Ming-Chang Chiang, Yu-Shuo Wu, Chen Chang, Jiang-Fan Chen, Jim-Min Fang, Yun-Lian Lin, Yijuang Chern